Evidence map›Paper›PMID 37643635›Full record

ReviewDigestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society2024

Present and future of endoscopy precision for inflammatory bowel disease.

Giovanni Santacroce, Irene Zammarchi, Chin Kimg Tan, Gaetano Coppola, Rachel Varley, Subrata Ghosh, Marietta Iacucci

Abstract readReview
In one paragraph

Review in Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Observational
  16. Review
  17. Review
  18. Review
  19. AI and endoscopy/histology in UC: the rise of machine.Therapeutic advances in gastroenterology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Giovanni SantacroceAPC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland.ORCID https://orcid.org/0000-0002-0544-0414
Irene ZammarchiAPC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland.
Chin Kimg TanAPC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland.
Gaetano CoppolaAPC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland.
Rachel VarleyDepartment of Gastroenterology, Mercy University Hospital, Cork, Ireland.
Subrata GhoshAPC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland.
Marietta IacucciAPC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland.ORCID https://orcid.org/0000-0002-3142-9550

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several advanced imaging techniques are now available for endoscopists managing inflammatory bowel disease (IBD) patients. These tools, including dye-based and virtual chromoendoscopy, probe-based confocal laser endomicroscopy and endocytoscopy, are increasingly innovative applications in clinical practice. They allow for a more in-depth and refined evaluation of the mucosal and vascular bowel surface, getting closer to histology. They have demonstrated a remarkable ability in assessing intestinal inflammation, histologic remission, and predicting relapse and favorable long-term outcomes. In addition, the future application of molecular endoscopy to predict biological drug responses has yielded preliminary but encouraging results. Furthermore, these techniques are crucial in detecting and characterizing IBD-related dysplasia, assisting endoscopic mucosal resection and submucosal dissection towards a surgery-sparing approach. Artificial intelligence (AI) holds great potential in this promising landscape, as it can provide an objective and reproducible assessment of inflammation and dysplasia. Moreover, it can improve the prediction of outcomes and aid in subsequent therapeutic decision-making. This review aims to summarize the promising role of state-of-the-art advanced endoscopic techniques and related AI-enabled models for managing IBD, paving the way for precision medicine.

Indexed as

Endoscopic Mucosal ResectionInflammatory Bowel DiseasesArtificial IntelligenceEndoscopyEndoscopy, GastrointestinalHumansInflammationartificial intelligencechromoendoscopyconfocal laser endomicroscopyendocytoscopyprecision medicine

Identifiers

PMID37643635
PMCPMC12136274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.